The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ADMA FINANCIAL STATEMENTS

ADMA Biologics Inc — balance sheet, income statement and cash flow trends

ADMAADMA Biologics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M400 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue512.3 M $Gross Profit331.5 M $ · 65%Operating Income216.5 M $ · 42%Pre-tax Income216.5 M $ · 42%Net Income to Owners169 M $ · 33%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue512.3 M $+8.0%
Gross Profit331.5 M $+31.9%
Operating Income216.5 M $+39.1%
EBITDA234.8 M $+44.0%
Net Income to Owners169 M $-19.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets684.2 M
  • Equity408.2 M $60%
  • Current Liabilities75.8 M $11%
  • Long-term Liabilities200.2 M $29%

Key Figures

YoY change
Total Assets684.2 M $+22.5%
Total Liabilities276 M $+72.4%
Total Equity408.2 M $+2.5%
Cash & ST Investments136 M $+50.7%
Total Debt203.8 M $+143.2%
Net Debt67.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0100 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
050 M100 M136.7 M $Operating-14.5 M $Investing-76.5 M $Financing45.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow136.7 M $+78.2%
Capital Expenditures20.3 M $+85.2%
Free Cash Flow116.5 M $+77.1%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ADMA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.